Cell and mouse study links ELAVL1 to cervical cancer progression
Cell, molecular and mouse experiments linked ELAVL1 overexpression to cervical cancer progression through a possible ACVRL1/CASP14 regulatory pathway.
Cell, molecular and mouse experiments linked ELAVL1 overexpression to cervical cancer progression through a possible ACVRL1/CASP14 regulatory pathway.
A retrospective study of 57,035 women in Shaanxi found HPV prevalence of 28.77%, persistent infection in 33.75% of those followed, ...
A retrospective study of 38 patients with advanced HPV16-positive cancers linked baseline and early serum protein measurements to outcomes from ...
A study of nearly 32,000 women in Shaanxi, China, found an overall HPV prevalence of 21.46 percent and showed that ...
Researchers fused split fluorescent protein fragments to the HPV16 capsid proteins L1 and L2, creating virus-like particles that report their ...
A new review in Virology Journal examines how siRNA and CRISPR/Cas gene-silencing technologies could target the HPV16 oncoproteins E5 and ...
A new review synthesizes two decades of evidence showing that HPV vaccination has progressed from reducing infection and precancer to ...
A new study reports that the natural flavonoid chrysin selectively reduced the viability of HPV16-positive CaSki cervical cancer cells while ...
A three-year study of over 23,000 women in Suzhou's Taihu region found a stable 13.20 percent HPV prevalence dominated by ...
A cross-sectional study of nearly 20,000 women in Shanxi, China, reports that high-risk HPV infection affects 10.9 percent of those ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine